General Physical and chemical properties Local anesthetic and antiarrhythmic drugs Application Metabolism Indications Usage and dosage Adverse effect Additional information Medicine interactions Precautions References
ChemicalBook > CAS DataBase List > Lidocaine hydrochloride

Lidocaine hydrochloride

General Physical and chemical properties Local anesthetic and antiarrhythmic drugs Application Metabolism Indications Usage and dosage Adverse effect Additional information Medicine interactions Precautions References
Product Name
Lidocaine hydrochloride
CAS No.
73-78-9
Chemical Name
Lidocaine hydrochloride
Synonyms
LIDOCAINE HCL;LIGNOCAINE HYDROCHLORIDE;Lidocaine HCI;rucainahydrochloride;duncainehydrochloride;gravocainhydrochloride;leostesinhydrochloride;xylocitinhydrochloride;2-diethylamino-2’,6’-acetoxylididehydrochloride;alpha-diethylamino-2,6-acetoxylidinehydrochloride
CBNumber
CB4117973
Molecular Formula
C14H23ClN2O
Formula Weight
270.8
MOL File
73-78-9.mol
More
Less

Lidocaine hydrochloride Property

Melting point:
80-82°C
storage temp. 
Inert atmosphere,2-8°C
Water Solubility 
Water : ≥ 36 mg/mL (132.94 mM)
InChI
InChI=1S/C14H22N2O.ClH/c1-5-16(6-2)10-13(17)15-14-11(3)8-7-9-12(14)4;/h7-9H,5-6,10H2,1-4H3,(H,15,17);1H
InChIKey
IYBQHJMYDGVZRY-UHFFFAOYSA-N
SMILES
C(NC1=C(C)C=CC=C1C)(=O)CN(CC)CC.[H]Cl
LogP
2.359 (est)
CAS DataBase Reference
73-78-9(CAS DataBase Reference)
EPA Substance Registry System
Acetamide, 2-(diethylamino)-N-(2,6-dimethylphenyl)-, monohydrochloride (73-78-9)
More
Less

Safety

RIDADR 
3249
HazardClass 
6.1(b)
PackingGroup 
III
Toxicity
LD50 oral in mouse: 220mg/kg
More
Less

Hazard and Precautionary Statements (GHS)

Symbol(GHS)
Signal word
Warning
Hazard statements

H302Harmful if swallowed

Precautionary statements

P264Wash hands thoroughly after handling.

P264Wash skin thouroughly after handling.

P270Do not eat, drink or smoke when using this product.

P301+P312IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.

P330Rinse mouth.

P501Dispose of contents/container to..…

More
Less

N-Bromosuccinimide Price

TRC
Product number
L397808
Product name
Lidocaine hydrochloride
Packaging
1g
Price
$40
Updated
2021/12/16
TRC
Product number
L397808
Product name
Lidocaine hydrochloride
Packaging
5g
Price
$60
Updated
2021/12/16
TRC
Product number
L397808
Product name
Lidocaine hydrochloride
Packaging
10g
Price
$80
Updated
2021/12/16
ChemScene
Product number
CS-3888
Product name
Lidocaine hydrochloride
Purity
99.46%
Packaging
10g
Price
$96
Updated
2021/12/16
ChemScene
Product number
CS-3888
Product name
Lidocaine hydrochloride
Purity
99.46%
Packaging
5g
Price
$60
Updated
2021/12/16
More
Less

Lidocaine hydrochloride Chemical Properties,Usage,Production

General

Lidocaine hydrochloride was synthesized by Löfgren and Lundquist in 1943, and was clinically introduced in 1948. It remains one of the most widely used local anaesthetics. It can be administered parenterally for a peripheral nerve block (PNB), intravenously, or applied topically at strengths of 2–4%. The addition of epinephrine 1:200 000 to 1:100 000 slows the vascular absorption of lidocaine and prolongs its effects.

Physical and chemical properties

Lidocaine hydrochloride is white and odorless crystal with bitter and numb taste. It is easily soluble in water, ethanol and organic solvents, but insoluble in ether. Aqueous solution in the case of acid and alkali do not break down, repeated autoclave rarely go bad.

Local anesthetic and antiarrhythmic drugs

Lidocaine hydrochloride is a local anesthetic and antiarrhythmic drug. It is clinically used for infiltration anesthesia, epidural anesthesia, surface anesthesia (including in the thoracoscopy or abdominal surgery for mucosal anesthesia) and nerve conduction block. The drug can also be used for acute myocardial infarction after ventricular premature beats and ventricular tachycardia, and for digitalis poisoning, cardiac surgery and ventricular arrhythmias caused by cardiac catheterization. But it is usually ineffective for supraventricular arrhythmias.
Lidocaine hydrochloride is an amide local anesthetic. After blood absorption or intravenous administration, the drug has obvious excitement and inhibition of biphasic effects for the central nervous system, and no excitement of the pioneer. With the dose increased, the role or toxicity increased, there is an anti-convulsive effect with sub-poisoning plasma concentration; Blood concentration of more than 5μg • ml-1 can occur convulsions. Lidocaine hydrochloride in low doses can promote outflow of K+ in cardiomyocytes, reduce myocardial autonomy, and has antiarrhythmic effects. In the treatment dose, lidocaine hydrochloride has no significant effect for the electrical activity of cardiomyocytes, atrioventricular conduction and myocardial contraction. Increased plasma concentration may cause slowing of heart conduction, atrioventricular block, inhibition of myocardial contractility and decreased cardiac output.

Application

Lidocaine hydrochloride is characterized by strong penetration, strong dispersion, rapidly onset. The anesthetic performance is twice that of procaine and the toxicity is1. There is an anesthetic effect after 5 minutes treatments, and anesthesia can last 1 to 1.5 hours, 50% longer than procaine. The drug is effective on the heart of the disease or arrhythmia caused by cardiac glycoside, but on the supraventricular tachycardia is poor. This product is fast and oral ineffective, with short duration, and often used as intravenous administration.

Metabolism

Lidocaine is metabolized by the liver with only a small amount (3%) found unchanged in urine. The three main mechanisms of metabolism are shown below: N-de-ethylation > monoethylglycinexylidide (MEGX) > glycinexylidide Hydrolysis of glycinexylidide 5-hydroxylation of lidocaine’s benzene ring Lidocaine possesses convulsant activity. Hepatic disease or reduced hepatic blood flow (as in congestive cardiac failure) will lower metabolic capacity.

Indications

  •  The drug can be used for infiltration anesthesia, epidural anesthesia, surface anesthesia and nerve conduction block
  • The drug can be used for acute myocardial infarction after ventricular premature beats and ventricular tachycardia, and for digitalis poisoning, cardiac surgery and ventricular arrhythmias caused by cardiac catheterization. But it is usually ineffective for supraventricular arrhythmias.

Usage and dosage

Surface anesthesia with solution of 2% to 5%.Infiltration anesthesia with solution of 0.25% to 0.5%, conduction anesthesia with 2%, each injection point, horse, cattle 8 to 12 ml, sheep 3 to 4 ml. Epidural anesthesia with 2% solution, horse, cow, 8 to 12 ml, dog, cat, 0.22 ml per kilogram of body weight. Subcutaneous injection with 2% solution, pig, sheep, 80 ml, horse, cow, 400 ml, dog,25 ml, cat, 8.5 ml.
Treatment of arrhythmia, intravenous injection: Per kg of dog’s body weight of the initial dose is 2 to 4 mg, followed by 25 to 75 micrograms per minute intravenous infusion; Cat initial dose of 250 to 500 micrograms, followed by intravenous infusion of 20 micrograms per minute.

Adverse effect

The incidence of adverse effect with lidocaine hydrochloride was about 6.3%. Most adverse effects are dose dependent. Adverse effects are drowsiness, dizziness, nausea, vomiting, burnout, euphoria, insanity, muscle convulsions, syncope, blurred vision, confusion and difficulty breathing. Large doses lead to severe sinus bradycardia, cardiac arrest, severe atrioventricular block and weakened myocardial contractility, reduced blood pressure and so on. Excess concentrations of lidocaine hydrochloride in the blood cause some problems. For example, atrial conduction slows, atrioventricular blocks (A-V-B), and inhibits myocardial contractility and cardiac output decreases. There are little allergic effects, such as erythema rash, angioneurotic edema and so on.

Additional information

Lidocaine is contraindicated in patients with known hypersensitivity to local anaesthetics of the amide type and in patients with porphyria. Reactions due to overdose with lidocaine (high plasma levels) are systemic and involve the central nervous and cardiovascular systems. Effects include medullary depression, tonic and clonic convulsions, and cardiovascular collapse Solutions in multidose vials may contain hydrobenzoate derivatives and have been associated with allergic reactions in some patients. As with all of the amide local anaesthetics protein binding is reduced in the neonate (50% versus 64% in the adult), which necessitates reduced doses if adverse reactions are to be avoided.

Medicine interactions

  •  Cimetidine and β-blockers can inhibit metabolism of lidocaine through liver, so that the blood concentration increases and adverse reactions occur in the heart and nervous system. We should adjust the dose of lidocaine hydrochloride.
  • Barbiturates can promote the metabolism of lidocaine hydrochloride, and the two drugs can cause bradycardia and sinus arrest.
  • Combined with procainamide, the drug can produce excessive delirium and hallucinations, but does not affect the product plasma concentration.
  • Isoprenaline Isoprinosine could increase the total clearance of lidocaine hydrochloride through increased liver blood flow; norepinephrine could reduce the total clearance of lidocaine hydrochlor through reduced liver blood flow.
  • The drug is contraindicated with phenobarbital, thiopental sodium, sodium nitroprusside, mannitol, amphotericin B, ampicillin, and sulfadiazine.

Precautions

  • Patients Allergic to other local anesthetics may be allergic to lidocaine hydrochloride.
  • The following circumstances with caution: Pregnancy, neonatal especially in premature infants, liver blood flow reduction, liver and kidney dysfunction, congestive heart failure, severe myocardial damage, low blood volume, shock and other patients.
  • Strictly grasp the concentration and total medication, excessive can cause convulsions and cardiac arrest; the body metabolism is slower than procaine, and there is accumulation, causing poisoning and convulsions.
  • Medication of the elderly should be adjusted the dose according to the needs and tolerability, and over the age of 70 should be halved.
  • Prevent straying into the blood vessels when anaesthetizing, prevent local anesthetic poisoning.
  •  We should pay attention to monitoring blood pressure, electrocardiogram, and with rescue equipment when arrhythmia Treatment; drug administration should be immediately discontinued in some circumstances. For example, ECG P-R interval prolongs or QRS wave widens, other arrhythmia or the original arrhythmia deteriorates.

References

https://www.drugbank.ca/drugs/DB00281
https://en.wikipedia.org/wiki/Lidocaine

Chemical Properties

White to Off-White Solid

Originator

Xylocaine,Astra,US,1949

Uses

Apply to affected site 5 to 10 minutes before procedure. Duration of anesthesia is relatively short (<1 hour).

Uses

Local anesthesic;Na+ channel blocker

Uses

Anesthetic (local); antiarrhythmic (class IB). Long-acting, membrane stabilizing agent against ventricular arrhythmia. Originally developed as a local anesthetic.

Definition

ChEBI: Lidocaine hydrochloride is the anhydrous form of the hydrochloride salt of lidocaine. It functions as both a local anesthetic and cardiac depressant, and is commonly used as an antiarrhythmic agent. Its potency is higher and its effects last longer than those of procaine, but its duration of action is shorter than that of bupivacaine or prilocaine.

Manufacturing Process

One mol of 2,6-xylidine is dissolved in 800 ml glacial acetic acid. The mixture is cooled to 10°C, after which 1.1 mol chloracetyl chloride is added at one time. The mixture is stirred vigorously during a few moments after which 1,000 ml half-saturated sodium acetate solution, or other buffering or alkalizing substance, is added at one time. The reaction mixture is shaken during half an hour. The precipitate formed which consists of ω-chloro-2,6- dimethyl-acetanilide is filtered off, washed with water and dried. The product is sufficiently pure for further treatment. The yield amounts to 70 to 80% of the theoretical amount.
One mole of the chloracetyl xylidide thus prepared and 2.5 to 3 mols diethyl amine are dissolved in 1,000 ml dry benzene. The mixture is refluxed for 4 to 5 hours. The separated diethyl amine hydrochloride is filtered off. The benzene solution is shaken out two times with 3N hydrochloric acid, the first time with 800 ml and the second time with 400 ml acid. To the combined acid extracts is added an approximately 30% solution of sodium hydroxide until the precipitate does not increase.
The precipitate, which sometimes is an oil, is taken up in ether. The ether solution is dried with anhydrous potassium carbonate after which the ether is driven off. The remaining crude substance is purified by vacuum distillation. During the distillation practically the entire quantity of the substance is carried over within a temperature interval of 1° to 2°C. The yield approaches the theoretical amount. MP 68° to 69°C. BP 180° to 182°C at 4 mm Hg; 159° to 160°C at 2 mm Hg. (Procedure is from US Patent 2,441,498.)

brand name

Alpha caine Hydrochloride (Carlisle); Anestacon (Polymedica); Laryng-O-Jet (International Medication); Lidocaton (Phar maton); Lidopen (Meridian); Xylocaine (Abraxis); Xylo caine (AstraZeneca); Xylocaine (Dentsply).

Therapeutic Function

Local anesthetic, Antiarrhythmic

Biological Functions

Lidocaine hydrochloride (Xylocaine) is the most commonly used local anesthetic. It is well tolerated, and in addition to its use in infiltration and regional nerve blocks, it is commonly used for spinal and topical anesthesia and as an antiarrhythmic agent. Lidocaine has a more rapidly occurring, more intense, and more prolonged duration of action than does procaine.

General Description

Lidocaine hydrochloride,2-(diethylamino)-2 ,6 -acetoxylidide monohydrochloride(Xylocaine), was conceived as a derivative of gramine(3-dimethylaminomethylindole) and introduced as a localanesthetic. It is now being used intravenously as a standardparenteral agent for suppression of arrhythmias associatedwith acute myocardial infarction and cardiac surgery.It isthe drug of choice for the parenteral treatment of prematureventricular contractions.

Mechanism of action

Lidocaine can block Na+ and K+  ion channels and regulate intracellular and extracellular calcium  concentrations through other ligand-gated ion channels. Lidocaine was  the first sodium channel blocker to be identified. Its main mechanism of  action is blocking voltage-gated Na+ channels (VGSC/NaVs).

Clinical Use

Lidocaine hydrochloride is a class IB antiarrhythmicagent with a different effect on the electrophysiologicalproperties of myocardial cells from that of procainamideand quinidine. It binds with equal affinity to the active (A)and inactive (I) Na+ ion channels. It depresses diastolic depolarizationand automaticity in the Purkinje fiber networkand increases the functional refractory period relative toaction potential duration, as do procainamide and quinidine.It differs from the latter two drugs, however, in that it doesnot decrease, and may even enhance, conduction velocity and increase membrane responsiveness to stimulation.There are fewer data available on the subcellular mechanismsresponsible for the antiarrhythmic actions of lidocainethan on the more established drug quinidine. It has been proposedthat lidocaine has little effect on membrane cation exchangeof the atria. Sodium ion entrance into ventricularcells during excitation is not influenced by lidocaine becauseit does not alter conduction velocity in this area.Lidocaine hydrochloride does depress Na+ influx duringdiastole, as do all other antiarrhythmic drugs, to diminishautomaticity in myocardial tissue. It also alters membraneresponsiveness in Purkinje fibers, allowing increased conductionvelocity and ample membrane potential at the timeof excitation.

Safety Profile

Poison by ingestion, intraperitoneal, intravenous, subcutaneous, intramuscular, and intratracheal routes. Human systemic effects: somnolence, respiratory depression, low blood pressure, cardiomyopathy includmg infarction, pulse rate increase. An experimental teratogen. Other experimental reproductive effects. A skin and eye irritant. An anesthetic. When heated to decomposition it emits very toxic fumes of NOx and HCl.

storage

Store in a tightly closed container at room temperature away from light and moisture. Do not store in the bathroom. Do not freeze. Keep all medications away from children and pets.

Lidocaine hydrochloride Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Lidocaine hydrochloride Suppliers

Wuhan Juchengyuan Biotechnology Co., Ltd
Tel
400-0276007 18062142210
Email
804180422@qq.com
Country
China
ProdList
153
Advantage
58
Hefei TNJ Chemical Industry Co.,Ltd.
Tel
551-65418679 15837135945
Fax
0551-65418697
Email
info@tnjchem.com
Country
China
ProdList
1889
Advantage
62
Changzhou Sunlight Farmacéutica.S.L.
Tel
0519-83138357,15851985467 13706121722
Fax
0519-83138041
Email
810308@sunlightchem.com
Country
China
ProdList
37
Advantage
60
Changzhou josenchem Pharmaceutical Chemical Material Co.,Ltd.
Tel
519-519-85286950 13338194135
Fax
0519-85286950
Email
info@josenchem.com
Country
China
ProdList
75
Advantage
58
Henan Qiande Pharmaceutical Co. LTD
Tel
19103869591
Email
1814581@qq.com
Country
China
ProdList
203
Advantage
58
Zhejiang Synose Tech Co., Ltd.
Tel
0579-89172082 18720986928
Fax
0579-89172082
Email
191094223@qq.com
Country
China
ProdList
63
Advantage
58
Beijing InnoChem Science & Technology Co., Ltd.
Tel
15652467323 15652467323
Email
sales@inno-chem.com.cn
Country
China
ProdList
8293
Advantage
58
Jiangsu Rongshuo Pharmaceutical Co., Ltd
Tel
15105138935 15105138935
Email
2622104407@qq.com
Country
China
ProdList
57
Advantage
58
Hebei mo Jin biotechnology co., ltd
Tel
15097329902
Fax
18503279000
Email
sales@hebeimojin.com
Country
China
ProdList
2254
Advantage
58
Changzhou Sunchem Pharmaceutical Chemical Material Co.,Ltd.
Tel
0519-85195575 15861192208
Fax
85195585
Email
850305@sunkechem.com
Country
China
ProdList
77
Advantage
69
JinYan Chemicals(ShangHai) Co.,Ltd.
Tel
13817811078
Fax
86-021-50426522,50426273
Email
sales@jingyan-chemical.com
Country
China
ProdList
9984
Advantage
60
Shanghai Longsheng chemical Co.,Ltd.
Tel
021-58099652-8005 13585536065
Fax
021-58099609
Email
bin.wu@shlschem.com
Country
China
ProdList
9816
Advantage
59
XiaoGan ShenYuan ChemPharm co,ltd
Tel
15527768850
Email
1791901229@qq.com
Country
China
ProdList
8849
Advantage
52
Tianjin heowns Biochemical Technology Co., Ltd.
Tel
400 638 7771
Email
sales@heowns.com
Country
China
ProdList
14443
Advantage
57
Shanghai Everchem Co., Ltd
Tel
86-29-81325371
Fax
+86-29-81325373
Email
info@everchem.cn
Country
China
ProdList
85
Advantage
62
Shanghai Sunway Pharmaceutical Technology Co., Ltd
Tel
+8618575662672 18575662672
Fax
021 51613951
Email
mzeng@3wpharm.com
Country
China
ProdList
9747
Advantage
57
Wuhan Fortuna Chemical Co., Ltd
Tel
027-027-59207852 13308628970
Fax
QQ3130921841
Email
buy@fortunachem.com
Country
China
ProdList
2893
Advantage
58
BioBioPha Co., Ltd.
Tel
0871-65217109 13211707573;
Fax
0871-65215563
Email
y.liu@mail.biobiopha.com
Country
China
ProdList
5654
Advantage
65
Beijing HuaMeiHuLiBiological Chemical
Tel
010-56205725
Fax
010-65763397
Email
waley188@sohu.com
Country
China
ProdList
12338
Advantage
58
NCE Biomedical Co.,Ltd.
Tel
4000-027-021 |24 +86-13986109188 | +86-15623472865 | +81-08033611988
Fax
+86-27-87599188
Country
China
ProdList
1494
Advantage
55
Nanjing Norris-Pharm Technology Co., Ltd
Tel
13901585132
Fax
+86-25-52131256
Email
799750417@qq.com
Country
China
ProdList
8888
Advantage
55
Haoyuan Chemexpress Co., Ltd.
Tel
021-58950125
Fax
(86) 21-58955996
Email
info@chemexpress.com
Country
China
ProdList
7553
Advantage
61
Nanjing Sunlida Biological Technology Co., Ltd.
Tel
025-57798810
Fax
025-57019371
Email
sales@sunlidabio.com
Country
China
ProdList
3750
Advantage
55
TargetMol Chemicals Inc.
Tel
021-33632979 15002134094
Fax
021-33632979
Email
marketing@targetmol.com
Country
China
ProdList
7934
Advantage
58
Shenzhen Shijingu Technology Co., Ltd
Tel
(0086)755-61930359 (0086)18038192047
Fax
(0086)755-84556470
Email
jo@pharmade.com
Country
China
ProdList
279
Advantage
58
GIHI CHEMICALS CO.,LTD
Tel
0086-571-86217390
Fax
0086-571-86217391
Email
Sales@gihichem.com
Country
China
ProdList
861
Advantage
58
Vientiane Tianjin Hengyuan Technology Co., Ltd.
Tel
15722085254
Fax
022-26358246
Email
phytochemical@126.com
Country
China
ProdList
813
Advantage
55
Shanghai Meishui Chemical Technology Co., Ltd
Tel
021-60549325 18616193163
Fax
021-33250306
Country
China
ProdList
4528
Advantage
56
Shanghai DiBai Chemicals Co., Ltd.
Tel
021-54359730 400-008-9730
Fax
021-54353864
Email
info@chemxyz.com
Country
China
ProdList
3993
Advantage
60
Changzhou Sunchem Pharmaceutical Chemical Material Co.,Ltd.
Tel
0519-85269522 13660798926
Fax
013660798926
Email
sunlight68@126.com
Country
China
ProdList
99
Advantage
60
Hunan HuaTeng Pharmaceutical Co., Ltd.,
Tel
400-8592883 15367835770
Fax
0731-82251112
Email
viola@huatengsci.com
Country
China
ProdList
5877
Advantage
58
Wuhan Dahua Pharmaceutical Co., Ltd.
Tel
027-59262863 13277907145 3091977954
Fax
027-59420980
Country
China
ProdList
4951
Advantage
58
Shanghai YuLue Chemical Co., Ltd.
Tel
021-60345187 13671753212
Fax
021-34702061
Email
lzz841106@aliyun.com
Country
China
ProdList
10287
Advantage
55
Hangzhou Zhenghan Biological Technology Co., Ltd.
Tel
+8618968058020
Fax
0571-88781753
Email
zhenghanbio@qq.com
Country
China
ProdList
28
Advantage
56
Mashilabs (Shanghai) Co.,Ltd.
Tel
021-00000000 19916721580
Fax
QQ:3154870176
Email
info@mashilabs.com
Country
China
ProdList
4115
Advantage
58
Shanghai HuanChuan Industry Co.,Ltd.
Tel
021-61478794
Fax
021-61478794
Email
sales@hcshhai.com
Country
China
ProdList
9798
Advantage
50
Wuhan Dahua Weiye Pharmaceutical Chemical Co., Ltd.
Tel
027-59420981,18702770802
Fax
027-83322098
Country
China
ProdList
1975
Advantage
50
Shanghai Yongye Biotechnology Co., Ltd.
Tel
86-021-61559134 15921386130
Fax
021-55068248
Email
3423497944@qq.com
Country
China
ProdList
8147
Advantage
55
Changzhou Josen Pharmaceutical Chemical Co., Ltd.
Tel
0519-85286950 15380036950
Fax
0519-83214720
Email
info@josenchem.com
Country
China
ProdList
55
Advantage
55
Credit Asia Chemical Co., Ltd.
Tel
+86 (21) 61124340
Fax
+86 (21) 6129-4103
Country
China
ProdList
9767
Advantage
58
Changzhou Bestar Industry Co.,Ltd.
Tel
0519-82309982
Fax
0519-82309985
Country
China
ProdList
129
Advantage
55
Chizhou Kailong Import and Export Trade Co., Ltd.
Tel
Fax
-
Email
xg01_gj@163.com
Country
China
ProdList
9503
Advantage
50
Sigma-Aldrich
Tel
021-61415566 800-8193336
Email
orderCN@merckgroup.com
Country
China
ProdList
51471
Advantage
80
Wuhan Senwayer Century Chemical Co.,Ltd
Tel
027-86652399 13627115097;
Fax
86-27-59707018
Email
sales@senwayer.com
Country
China
ProdList
266
Advantage
55
Jinan Putubio Tech Co., Ltd.
Tel
+86 (531) 8099-2215
Fax
+86 (531) 8099-2215
Email
putubio@outlook.com
Country
China
ProdList
1261
Advantage
55
Hangzhou Dingyan Chem Co., LTD
Tel
0571-0571-87157530-8001-8006 18049756717
Fax
0571-87156470
Email
sales@dingyanchem.com
Country
China
ProdList
1997
Advantage
58
ShangHai Siyan Biological Technology Co., Ltd.
Tel
021-50908862,442785678,326799392 18721037013
Fax
021-50908862
Email
siyansales@126.com
Country
China
ProdList
9638
Advantage
58
Henan CoreyChem Co., Ltd
Tel
0371-86658258
Fax
0371-60996044
Email
info@coreychem.com
Country
China
ProdList
10457
Advantage
58
Jinan Jianfeng Chemical Co., Ltd.
Tel
0531-88110457 15562555968
Email
info@pharmachemm.com
Country
China
ProdList
166
Advantage
58
Guangzhou QiYun Biotechnology Co., Ltd.
Tel
020-61288194 61288195
Fax
020-61288700
Email
505721671@qq.com
Country
China
ProdList
3868
Advantage
58
More
Less

View Lastest Price from Lidocaine hydrochloride manufacturers

Dorne Chemical Technology co. LTD
Product
Lidocaine hydrochloride 73-78-9
Price
US $1.00-1.00/kg
Min. Order
1kg
Purity
99%
Supply Ability
10 tons
Release date
2024-03-26
Hebei Kangcang new material Technology Co., LTD
Product
Lidocaine hydrochloride 73-78-9
Price
US $20.00-10.00/kg
Min. Order
1kg
Purity
98%
Supply Ability
20
Release date
2024-03-27
Nanjing Deda New Material Technology Co., Ltd
Product
Lidocaine HCL 73-78-9
Price
US $5.00-1.00/kg
Min. Order
1kg
Purity
99.5
Supply Ability
10 ton per month
Release date
2023-11-23

73-78-9, Lidocaine hydrochlorideRelated Search:


  • LIGNOCAINE HYDROCHLORIDE
  • LIDOCAINE HYDROCHLORIDE
  • LIDOCAINE HCL
  • Lidocaine hydrochloride CP2000,BP98
  • a-(diethylamino)-26-acetoxylidideHCl
  • a-(diethylamino)-26-acetoxylididehydrochloride
  • Acetamide, 2-(diethylamino)-N-(2,6-dimethylphenyl)-, monohydrochloride 2-(diethylamino)-n-(2,6-dimethylphenyl)-acetamid monohydrochloride alpha-diethylamino-2,6-acetoxylidine hydrochloride anestacon hydrochloride duncaine hydrochloride
  • 2-(Diethylamino)-N-(2,6-dimethylphenyl)-acetamide hydrochloride
  • 6’-acetoxylidide,2-(diethylamino)-2hydrochloride
  • 6’-acetoxylidide,2-(diethylamino)-2monohydrochloride
  • Acetamide,2-(diethylamino)-N-(2,6-diethylphenyl)-,monohydrochloride
  • Acetamide,2-(diethylamino)-N-(2,6-dimethylphenyl)-,monohydrochloride
  • alpha-diethylamino-2,6-acetoxylidinehydrochloride
  • anestaconhydrochloride
  • duncainehydrochloride
  • gravocainhydrochloride
  • isicainehydrochloride
  • leostesinhydrochloride
  • lidocainhydrochloride
  • lidothesinhydrochloride
  • n-(diethylaminoacetyl)-2,6-dimethylanilinehydrochloride
  • omega-diethylamino-2,6-dimethylacetanilidehydrochloride
  • rucainahydrochloride
  • s202
  • v262
  • xycainehydrochloride
  • xylestesinhydrochloride
  • xylocainehydrochloride
  • xylocard
  • xylocitinhydrochloride
  • xyloneural
  • xylotoxhydrochloride
  • Basicaina Monohydrate
  • Batixim Monohydrate
  • Dynexan Monohydrate
  • Heweneural Monohydrate
  • Licain Monohydrate
  • LIDOCAINE HYDROCHLORIDE ANHYDROUS USP
  • 2-(diethylamino)-n-(2,6-dimethylphenyl)-acetamidmonohydrochloride
  • 2-diethylamino-2’,6’-acetoxylididehydrochloride
  • LIONCAINEHYDROCHLORIDE
  • Lidociane Hydrochloride
  • Lidocaine HCL (BP/USP)
  • Lidocaie Hydrochloride
  • 2-DIETHYLAMINO-N-(2'6'-DIMETHYLPHENYL)ACETAMIDE HCL
  • 2-DIETHYLAMINO-N-[2,6-DIMETHYLPHENYL]ACETAMIDE HCL
  • ALPHA-(DIETHYLAMINO)-2',6'-ACETOXYLIDIDE HYDROCHLORIDE
  • A-(DIETHYLAMINO)-2 6-DIMETHYLACETANILIDE HYDROCHLORIDE
  • Lidocaine hcl powder
  • Lithium Claviate
  • LIDOCAINE HYDROCHLORIDE (LIGNOCAINE HYDROCHLORIDE)
  • Lidocaine HCl CAS 73-78-9 Pharmaceutical Raw Material Lidocaine kf-wang(at)kf-chem.com
  • 99% Lidocaine Hydrochloride Pharmaceutical Raw Materials 73-78-9 Lidocaine HCl CAS NO.73-78-9
  • A-(DIETHYLAMINO)-2 6-DIMETHYLACETANILIDE H
  • Lidocaine hydrochloride cas 73-78-9 (skype:lisa_21819)
  • Lidocaine hydrochloride 2-(Diethylamino)-N-(2,6-dimethylphenyl)-acetamide hydrochloride
  • Coluracetam powder
  • Lidocainhydrochlorid